EUVIMEDObjevte EUVIMED
Crossref

Saikosaponin D Regulates HK2 ‐Mediated Glycolytic Lactate Signaling to Alleviate CKD ‐Induced Renal Fibrosis

Jian Jia, Long-Hao Jia, Qiu-Xiang Bai, Ping Li, Rui-Zhi Tan, Li Wang iD

Phytotherapy Research · 2026-02 · 40 (2) · 812-828

DOI: 10.1002/ptr.70187 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-01-08. Written by Jian Jia and 5 co-authors. Institution: Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical Universit…. Major MEDLINE topics: Saponins, Oleanolic Acid, Renal Insufficiency, Chronic, Hexokinase. Cited 2 times so far (Crossref); 42 references. Funded by: Sichuan Province Science and Technology Support Program, Southwest Medical University Technology Program, The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Chronic kidney disease (CKD) is characterized by tubulointerstitial fibrosis and has a high prevalence, with limited clinical treatment options available. Saikosaponin D (SSD) is a major component of the traditional Chinese medicine compound Chaihuang Yishen Granules (CHYS) and exhibits favorable anti–fibrotic effects. However, its role and underlying mechanisms in renal fibrosis remain unclear. To elucidate the protective effects of SSD on CKD‐induced renal fibrosis and investigate the underlying mechanism by which SSD alleviates renal fibrosis through regulating hexokinase‐2 (HK2)‐mediated Smad3 activation, CKD models were established using unilateral ureteral obstruction (UUO) and adenine (ADE) induction. Subsequently, SSD was administered via oral gavage as a therapeutic intervention to observe its protective effects against CKD‐induced renal fibrosis. Mechanistically, in vitro experiments involving HK2 overexpression and knockdown, as well as the use of SIS3 to inhibit Smad3 activation, evaluated the regulatory role of HK2 on glycolysis and Smad3. The results demonstrated that SSD treatment significantly improved the abnormal serum creatinine (CRE) and blood urea nitrogen (BUN) levels in CKD mice, alleviated renal pathological damage, and reduced the expression of fibrosis‐related proteins (Col‐I, FN, α‐SMA). HK2 was found to promote glycolysis‐related enzymes and Smad3 activation. Inhibition of Smad3 activation with 4 μM SIS3 significantly attenuated TGF‐β‐induced fibrosis in tubular cells but had no effect on HK2 expression or glycolysis. Direct suppression of LDHA‐mediated lactate production using 25 mM oxamic acid sodium (OX) markedly reduced HK2‐induced Smad3 activation and tubular cell fibrosis. This study reveals that SSD significantly alleviates CKD‐induced renal fibrosis by inhibiting HK2‐mediated Smad3 activation. Lactate, not only as the end product of HK2‐driven glycolysis, but also acts as a signaling mediator in HK2‐regulated Smad3 activation, facilitating its activation.

Subjects

MeSH terms (MEDLINE)

SaponinsOleanolic AcidRenal Insufficiency, ChronicHexokinaseLactic AcidAnimalsFibrosisSmad3 ProteinGlycolysisMiceMaleSignal TransductionKidneyHumansMice, Inbred C57BLCell Line

Author keywords

Smad3chronic kidney diseaseglycolysishexokinase‐2saikosaponin D

Substances

SaponinsOleanolic Acidsaikosaponin DSmad3 ProteinHexokinaseLactic AcidSmad3 protein, mouse

Authors and institutions

  • Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
  • Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing, China.
  • Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, China.

ORCID profiles: Li Wang

Funding

  • Sichuan Province Science and Technology Support Program
  • Southwest Medical University Technology Program
  • The Science and Technology Strategic Cooperation Programs of Luzhou Municipal People's Government and Southwest Medical University
  • Sichuan Provincial Science and Technology Support Program

Cite

APA

Jia, J., Jia, L. H., Bai, Q. X., Li, P., Tan, R. Z., & Wang, L. (2026). Saikosaponin D Regulates HK2 ‐Mediated Glycolytic Lactate Signaling to Alleviate CKD ‐Induced Renal Fibrosis. Phytotherapy Research, 40(2), 812-828. https://doi.org/10.1002/ptr.70187

Vancouver

Jia J, Jia LH, Bai QX, Li P, Tan RZ, Wang L. Saikosaponin D Regulates HK2 ‐Mediated Glycolytic Lactate Signaling to Alleviate CKD ‐Induced Renal Fibrosis. Phytotherapy Research. 2026;40(2):812-828. doi:10.1002/ptr.70187

BibTeX
@article{Jia2026,
  author = {Jia, Jian and Jia, Long-Hao and Bai, Qiu-Xiang and Li, Ping and Tan, Rui-Zhi and Wang, Li},
  title = {Saikosaponin D Regulates HK2 ‐Mediated Glycolytic Lactate Signaling to Alleviate CKD ‐Induced Renal Fibrosis},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {812--828},
  doi = {10.1002/ptr.70187}
}
Start for free →